DNA methylation and hepatic insulin resistance and steatosis

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 4, 2012, Pages 350-356

  Sookoian, Silvia ^a   Pirola, Carlos J ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

acetylation; deacetylation; DNA methylation; epigenetics; fatty liver; histones; mitochondria; nonalcoholic steatohepatitis; PGC1a; PPARGC1A

Indexed keywords

INSULIN; MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRIACYLGLYCEROL;

ACETYLATION; BIOACCUMULATION; COMORBIDITY; DEACETYLATION; DISEASE ASSOCIATION; DNA METHYLATION; DYSLIPIDEMIA; EPIGENETICS; EPIGENOME; GENOME; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER METABOLISM; LIVER MITOCHONDRION; METABOLIC REGULATION; MITOCHONDRIAL DNA DISORDER; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROMOTER REGION; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

DIET; DNA METHYLATION; EPIGENESIS, GENETIC; FATTY LIVER; HEAT-SHOCK PROTEINS; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MITOCHONDRIA; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 84862152605     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283546f9f     Document Type: Review

References (41)

1. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28:27-38
2. Targher G, Arcaro G. Nonalcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191:235-240
3. Sookoian S, Pirola CJ. Nonalcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008; 49:600-607
4. Sookoian S, Castano GO, Burgueno AL, et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis 2010; 209:585-591
5. Sookoian S, Gianotti TF, Rosselli MS, et al. Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. Atherosclerosis 2011; 218:378-385
6. Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009; 106:15430-15435
7. Sookoian S, Garcia SI, Porto PI, et al. Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. J Mol Endocrinol 2005; 35: 373-380
8. Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 2006; 116:615-622
9. Sookoian S, Rosselli MS, Gemma C, et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter. Hepatology 2010; 52:1992-2000
10. Barres R, Osler ME, Yan J, et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 2009; 10:189-198
11. Ling C, Del GS, Lupi R, et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008; 51:615-622
12. Hwang JH, Stein DT, Barzilai N, et al. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 2007; 293:E1663-E1669
13. Korenblat KM, Fabbrini E, Mohammed BS, et al. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008; 134:1369-1375
14. Kim SC, Sprung R, Chen Y, et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006; 23:607-618
15. Rodgers JT, Lerin C, Haas W, et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434:113-118
16. Canto C, Auwerx J. PGC-1alpha, SIRT1 and A.M.P.K., an energy sensing network that controls energy expenditure. Curr Opin Lipidol 2009; 20:98-105
17. Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem 2005; 280:16456-16460
18. Lerin C, Rodgers JT, Kalume DE, et al. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab 2006; 3:429-438
19. Wilson BJ, Tremblay AM, Deblois G, et al. An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha. Mol Endocrinol 2010; 24:1349-1358
20. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42:105-116
21. Charest-Marcotte A, Dufour CR, Wilson BJ, et al. The homeobox protein Prox1 is a negative modulator of ERR{alpha}/PGC-1{alpha} bioenergetic functions. Genes Dev 2010; 24:537-542
22. Jeninga EH, Schoonjans K, Auwerx J. Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene 2010; 29:4617-4624
23. Teperino R, Schoonjans K, Auwerx J. Histone methyl transferases and demethylases; can they link metabolism and transcription? Cell Metab 2010; 12:321-327
24. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127:1109-1122
25. Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007; 450:712-716
26. Shock LS, Thakkar PV, Peterson EJ, et al. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc Natl Acad Sci USA 2011; 108:3630-3635
27. Carabelli J, Burgueno AL, Rosselli MS, et al. High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia. J Cell Mol Med 2011; 15:1329-1338
28. Jeong JW, Bae MK, Ahn MY, et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002; 111:709-720
29. O'Hagan KA, Cocchiglia S, Zhdanov AV, et al. PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. Proc Natl Acad Sci USA 2009; 106:2188-2193
30. Jiang M, Zhang Y, Liu M, et al. Hypermethylation of hepatic glucokinase and Ltype pyruvate kinase promoters in high-fat diet-induced obese rats. Endocrinology 2011; 152:1284-1289
31. Lomba A, Milagro FI, Garcia-Diaz DF, et al. Obesity induced by a pair-fed high fat sucrose diet: methylation and expression pattern of genes related to energy homeostasis. Lipids Health Dis 2010; 9:60
32. Pogribny IP, Tryndyak VP, Bagnyukova TV, et al. Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol 2009; 51:176-186
33. Li J, Huang J, Li JS, et al. Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets. J Hepatol 2012; 56:900-907
34. Xiong Y, Lei QY, Zhao S, et al. Regulation of glycolysis and gluconeogenesis by acetylation of PKM and PEPCK. Cold Spring Harb Symp Quant Biol 2011. [Epub ahead of print]
35. Gong L, Pan YX, Chen H. Gestational low protein diet in the rat mediates Igf2 gene expression in male offspring via altered hepatic DNA methylation. Epigenetics 2010; 5:619-626
36. Plosch T, Gellhaus A, van Straten EM, et al. The liver X receptor (LXR) and its target gene ABCA1 are regulated upon low oxygen in human trophoblast cells: a reason for alterations in preeclampsia? Placenta 2010; 31:910-918
37. Strakovsky RS, Zhang X, Zhou D, et al. Gestational high fat diet programs hepatic phosphoenolpyruvate carboxykinase gene expression and histone modification in neonatal offspring rats. J Physiol 2011; 589 (Pt 11):2707-2717
38. Burgueño AL, Cabrerizo R, Gonzales Mansilla N, et al. Maternal high fat intake during pregnancy programs metabolic syndrome-related phenotypes through liver mitochondrial DNA copy number and transcriptional activity of liver PPARGC1A. J Nutr Biochem 2012. [Epub ahead of print]
39. Gemma C, Sookoian S, Alvarinas J, et al. Mitochondrial DNA depletion in small-and large-for-gestational-age newborns. Obesity (Silver Spring) 2006; 14:2193-2199
40. Gemma C, Sookoian S, Alvarinas J, et al. Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity (Silver Spring) 2009; 17:1032-1039
41. Mortensen OH, Olsen HL, Frandsen L, et al. A maternal low protein diet has pronounced effects on mitochondrial gene expression in offspring liver and skeletal muscle; protective effect of taurine. J Biomed Sci 2010; 17 (Suppl. 1): S38